grcm39 mouse reference genome (10X Genomics)
86
Structured Review
10X Genomics
grcm39 mouse reference genome
Grcm39 Mouse Reference Genome, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grcm39+mouse+reference+genome/genome+human+reference/bio_rxiv__2025__07__11__664370-56-28-32
Average 86 stars, based on 1 article reviews
Grcm39 Mouse Reference Genome, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/grcm39+mouse+reference+genome/genome+human+reference/bio_rxiv__2025__07__11__664370-56-28-32
Average 86 stars, based on 1 article reviews
grcm39 mouse reference genome - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
other:Article Title: Single-cell transcriptomics reveal alveolar macrophages-specific responses in single-hit ozone exposure model in mice Article Snippet: Raw FASTQ files were demultiplexed and the unique transcripts with unique molecular identifiers (UMI) were counted using the Cell Ranger pipeline (v8.0.0), and individual reads were aligned to Article Title: Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer. Article Snippet: Article Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer Graphical abstract Highlights • Tailored mutagenic chemical treatment leads to epigenetic loss of Msh2 • Temozolomide plus cisplatin induces high TMB and microsatellite instability • Chemically induced MMRd genotype generates high immunogenicity in preclinical models • In treated patients, MMRd signatures emerged but no responses were observed Authors Benoit Rousseau, Mitesh Patel, Oliver Artz, ..., Elisa de Stanchina, Neil H. Segal, Luis A. Diaz, Jr.. Correspondence diazl5@mskcc.org In brief Rousseau et al. show that tailored mutagenic chemical treatment induces a mismatch repair deficient genotype by epigenetic Msh2 silencing leading to potent immune response in immunoresistant tumor models and sensitizing to PD-1 blockade.. Rousseau et al., 2025, Cancer Cell 43, 1–15 July 14, 2025 © 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. https://doi.org/10.1016/j.ccell.2025.05.010 ll |